Skip to content Skip to footer

Research summary · · 4 min read

In short

  • Fifty-two people with metastatic cancer and anxiety or depression took part in a three-day group retreat with one 25 mg psilocybin session.
  • There were no unattended episodes of distress and no serious adverse events on the dosing day.
  • Twenty-eight days later, anxiety and depression scores had fallen and demoralisation and quality of life had improved.

What the researchers did

Researchers in the USA ran eight retreats with a fixed team of facilitators, slowly increasing the group from five to eight participants as they learned what was safe. Participants had cancer that could no longer be cured, and most were still receiving cancer treatment. The main question was practical: can one team care for a small group in the same session without anyone being left alone in distress?

What they found

Nobody needed a backup facilitator for unattended distress in any session. Every participant said they had received enough attention and that the others in the group had been well supported. Side effects were mild and short-lived, such as nausea or malaise.

Anxiety and depression scores dropped between the start and 28 days after dosing, and participants reported less demoralisation and better quality of life. The authors suggest the group format may offer an experience as deep as individual sessions.

Why it matters

At the end of life the questions the Numinous Way cares about become most urgent: meaning, connection and facing death. Many people imagine psychedelic therapy as something done alone with one therapist. This study suggests that a group, carefully held, can be safe and supportive, and may add something of its own: the experience of not being alone. That is close to what we see in our own small-group retreats.

Keep in mind

There was no control group, so the improvements cannot be put down to psilocybin alone, and the efficacy results were exploratory. Participants were carefully screened and supported; the findings do not apply to unsupervised use.

Not sure where to start?

Book a free 30-minute call with one of our practitioners and ask your questions, with no obligation.

Book a free call

This summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.

You may also like

All articles

Danielle Tanner

Danielle TannerDanielle is a relational body psychotherapist and clinical supervisor who facilitates our retreats and integration work. More about Danielle

Find Us

3 Hill Street, New Town
Edinburgh, EH2 3JP

More Info
Subscribe to Our Newsletter

Numinous Ways © 2026. All Rights Reserved.